IMU 0.00% 4.9¢ imugene limited

Media Thread, page-8951

  1. 3,414 Posts.
    lightbulb Created with Sketch. 293
    Bingo.
    The “old guard” won’t be able to compete against OnCARlytics, because there is nothing on the market that does, so they will have to buy it if they want it, but the price won’t be cheap if it unlocks a previously untapped $400B p.a. market.
    One day the broader population might wake up and realise what IMU have.
    The last share price rise was due to speculation about a HerVaxx deal I believe, what will be the speculation value of a possible cure, or at least an extension of quality of life, for solid tumour sufferers?
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.